British Ophthalmological Surveillance Unit obtains further funding

Article

Fight for Sight has given further funding to the British Ophthalmological Surveillance Unit (BOSU) for research into preventing sight loss and treating eye disease.

Fight for Sight has given further funding to the British Ophthalmological Surveillance Unit (BOSU) for research into preventing sight loss and treating eye disease.

BOSU provides ophthalmologists with a Reporting Card so they can alert researchers to uncommon eye disease cases. The data collected goes towards research projects investigating rare eye disorders.

Dr Rashmi Matthew, who used BOSU to develop the British Ocular Syphillis Study, said, "BOSU has been invaluable in furthering our understanding of ocular syphilis- a rare form of the sexually transmitted disease. Through the support of Fight for Sight and the Royal College of Ophthalmologists, many more researchers will benefit from this essential resource, expanding our knowledge of rare eye conditions and disorders.”

Chief Executive of Fight for Sight, said, “Ophthalmologists play a vital role in the identification and reporting of uncommon eye diseases, as well as rare complications of more common eye conditions, and their participation in BOSU has a huge impact on medical research into eye disease. Through our work with BOSU, we hope to inspire even more people to help raise awareness within the medical profession of the less common conditions under investigation.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.